Published 21 minutes ago • loading... • Updated 36 minutes ago
Alkermes to Present at Upcoming Investor Conferences
The company plans a Jefferies fireside chat and a psychedelics panel, with webcasts and replays available for 90 days after each event.
On Wednesday, November 4, 2026, multiple biopharmaceutical companies including Incyte and Definium Therapeutics announced participation in upcoming November investor conferences.
Management teams use these conferences to provide updates on clinical pipelines and engage directly with investors regarding long-term corporate strategies and financial goals.
Definium Therapeutics will present at the Stifel 2026 Healthcare Conference and the Jefferies Global Healthcare Conference in London, with a fireside chat on November 17 and psychedelics panel on November 19.
Incyte scheduled presentations for the Wolfe Research Healthcare Conference on November 10 and the UBS Global Biopharma Conference on November 17, while Alkermes plc confirmed management participation in two upcoming events.
Beyond healthcare, Sterling Infrastructure, Inc. will attend the Baird Global Industrial Conference in Chicago on November 11 to present its industrial and infrastructure project portfolio.